Skip to main content
Navigating the shift from volume to value in healthcare
HI Summits
Policy
Population Health
Analytics/AI
Cybersecurity
Sections
HI Summits
Policy
Population Health
Analytics/AI
Cybersecurity
Finance/Revenue Cycle
Interoperability & HIE
Clinical IT
Imaging
Special
Webinars
Videos
Special Features
White Papers
Podcasts
Innovator Awards
Impact Awards
Contact
About Us
Newsletter Subscription
Advertise
Issue Archives
Contact Us
Affiliated Brands
HEALTHCARE PURCHASING NEWS
MEDICAL LABORATORY OBSERVER
Follow us on
https://www.facebook.com/HealthcareInnovationGroup
https://www.instagram.com/healthcare_innovation/
https://www.linkedin.com/company/healthcareinnovation/
https://twitter.com/HCInnovationGrp
https://www.youtube.com/@HealthcareInnovationGroup
Pharmacoeconomics and Prescription Drugs
ID 276938 © Gordon Swanson | Dreamstime.com
State Drug Pricing Advocacy Briefing
Pharmacoeconomics and Prescription Drugs
Legislative Efforts to Curb Prescription Drug Prices Gain Momentum Across the U.S.
Virginia's General Assembly is set to vote on the Affordable Medicine Act, aiming to extend Medicare drug price negotiations to state plans
April 22, 2026
ID 108726739 © Maria Dryfhout | Dreamstime.com
Top Medicare Part D Drug Prices Almost Doubled
Pharmacoeconomics and Prescription Drugs
Top Medicare Part D Drug Prices Almost Doubled
Jan. 13, 2025
ID 8355974 © Johnsroad7 | Dreamstime.com
dreamstime_xxl_8355974
Policy & Value-Based Care
AMCP’s CEO Looks at the Complex Landscape Around Prescription Drug Costs
Aug. 22, 2024
Looking for Something?
Load More Content
